Efficacy of a skin barrier repair cream (Dermalex Eczema/ Atopifin) in atopic dermatitis patients - Skin barrier repair cream in atopic dermatitis

Academisch Medisch Centrum0 个研究点目标入组 30 人开始时间: 待定最近更新: 2024年4月29日

适应症

试验速览

暂无简介。

•Clinically diagnosed atopic dermatitis
•Mild to moderate atopic dermatitis
•At least two symmetrical (i.e. left and right side of the body) skin sites with comparable atopic dermatitis severity
•Age between 18 and 70 years

•- Other skin disease other than AD.
•- Use of antihistamines prior to (72 hours) the study and/or expected use during the study.
•- Use of antibiotics prior to (4 weeks) the study and/or expected use during the study.
•- Use of inflammation suppressing medicines (e.g. corticosteroids, NSAIDs) prior to (4 weeks) the study and/or expected use during the study
•- Use of systemic suppressing drugs (e.g. prednisone, methothrexate) prior to (4 weeks) the study and/or expected use during the study
•-Severe disorders within the last 6 months before study (e.g. cancer, acute cardiac or circularity disorders, HIV, infectious hepatitis)
•- Investigator's uncertainty about the willingness or ability of the patient to comply with the protocol requirements.

发起方